Edward Pershing - 02 Dec 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
CEO, Director
Signature
/s/ Edward Pershing
Issuer symbol
PVCT
Transactions as of
02 Dec 2024
Transactions value $
$0
Form type
4
Filing time
04 Dec 2024, 19:26:46 UTC
Previous filing
02 Dec 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVCT Stock Options (Right to Buy) Award $0 +25.5M $0.00 25.5M 02 Dec 2024 Common Stock 25.5M $0.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in three equal annual installments beginning on December 2, 2024.